Your session is about to expire
← Back to Search
Dietary Supplement
Treatment Arm for Coronavirus
N/A
Waitlist Available
Led By James Veltmeyer, MD
Research Sponsored by Therapeutic Solutions International
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12 weeks
Awards & highlights
Study Summary
This trial will test if a nutritional supplement can help reduce infection risk in people who are likely to get COVID-19.
Eligible Conditions
- Coronavirus
- Coronavirus Infection
- COVID-19
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 12 weeks
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12 weeks
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Prevention of COVID-19
Secondary outcome measures
Safety as determined by presence or absence of Adverse Events and Serious Adverse Events
Trial Design
1Treatment groups
Experimental Treatment
Group I: Treatment ArmExperimental Treatment1 Intervention
Patients will receive 2 pills of QuadraMune(TM) daily for 12 weeks
Find a Location
Who is running the clinical trial?
Therapeutic Solutions InternationalLead Sponsor
2 Previous Clinical Trials
60 Total Patients Enrolled
James Veltmeyer, MDPrincipal InvestigatorTherapeutic Solutions International
1 Previous Clinical Trials
30 Total Patients Enrolled
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
Share this study with friends
Copy Link
Messenger